Mitogenesis, micronuclei, and carcinogenesis in the rat liver: some basic inconsistencies

Area of Science:

• Toxicology
• Hepatology
• Genotoxicity

Background:

• Methylclofenapate (MCP) is a known rodent liver carcinogen, mitogen, and peroxisome proliferator.
• The rat liver micronucleus assay is a standard genotoxicity test.
• Understanding mitogenic effects is crucial for interpreting liver micronucleus assay results.

Purpose of the Study:

• To investigate methylclofenapate (MCP) as a chemical mitogen in the rat liver micronucleus assay.
• To compare the effects of MCP with 4-acetylaminofluorene (4AAF) and partial hepatectomy on micronucleated hepatocyte (MH) induction.
• To assess the relationship between mitogenesis and MH yield in N-nitrosodimethylamine (NDMA)-initiated livers.

Main Methods:

• Comparison of three mitogenic stimuli: MCP, 4-acetylaminofluorene (4AAF), and 2/3 partial hepatectomy.
• Initiation of rat livers with N-nitrosodimethylamine (NDMA).
• Monitoring of micronucleated hepatocytes (MH) over time and quantification of MH induction magnitude.
• Description of acridine orange staining for isolated hepatocytes.

Main Results:

• Unexpected differences observed in MH induction profiles and magnitude between MCP, 4AAF, and partial hepatectomy.
• No correlation found between the magnitude of MH induction and the degree of mitogenesis.
• The yield of MH in the rat liver micronucleus assay is not solely dependent on the level of DNA damage from the initiating agent.

Conclusions:

• Caution is advised when interpreting rat liver micronucleus assay data for chemicals with unknown carcinogenicity.
• Mitogenesis level does not directly predict micronucleated hepatocyte yield.
• The study highlights the complexity of interpreting genotoxicity data in the context of mitogenic stimulation.